Skip to main content

Share story

Security

Greenberg Traurig clients sue over data breach

Greenberg Traurig clients sue over data breach Image: Primary
A proposed class of Greenberg Traurig clients has sued the law firm in New York federal court, alleging that it failed to protect their personal information before a preventable data breach. The plaintiffs also allege that the firm waited two weeks to notify clients. The action seeks injunctive and other equitable relief intended to protect client data. The allegations have not been adjudicated, and the available report does not establish the breach's technical cause, the number of affected clients or the categories of information exposed.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Law360 and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

Security
Security

Gyazo breach exposed metadata for 490 million images

A breach at screenshot-sharing service Gyazo exposed nearly 24 million customer records and an additional 490 million image-metadata records, Infosecurity Magazine reported. Attackers exploited an upload-server vulnerability, gain...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...